Unity Biotechnology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Unity Biotechnology, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $5.80 million as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2025-03-07
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.80M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.63M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.46M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.29M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2024-12-31 | $5.80M 10-K · filed 2025-03-07 |
| 2023-12-31 | $5.63M 10-K · filed 2024-04-15 |
| 2022-12-31 | $5.46M 10-K · filed 2023-03-15 |
| 2021-12-31 | $5.29M 10-K · filed 2022-03-15 |
| 2020-12-31 | $5.12M 10-K · filed 2021-03-23 |
| 2020-03-31 | $4.96M 10-Q · filed 2020-05-07 |